IMI's neurodegeneration projects gather at 29th Alzheimer Europe Conference in The Hague



The NEURONET project is organising its annual networking and communication event this week in The Hague to showcase the best of IMI's neurodegeneration portfolio.


Project coordinator, Dr. Mercè Boada will present the MOPEAD project in a parallel session with three other IMI projects aimed at diagnosis, patient engagement and trials. The event is taking place at the 29th Alzheimer Europe conference and will include four parallel sessions which introduce the state of the art in European neurodegeneration research.


The Alzheimer Europe Conference is a highly anticipated annual event which brings together not only researchers and industry representatives from all over Europe, but also people with dementia, their families, volunteers and staff from Alzheimer associations together with policy makers. This makes is an excellent forum for dementia experts to meet and exchange knowledge and experience.


Follow all news from the event on our Twitter @MopeadEU and stay up to date with all our upcoming conferences on our website here.

Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations